Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
BMC Cancer|November 29, 2013
Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort studyMaria Theresa Redaniel, Richard M Martin, David Gillatt, et al.
Neurourology and Urodynamics|June 2, 2026
Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta-AnalysisHussain Arshad, Raiyana Nuha, Shehab Khashaba, et al.
BJU International|February 12, 2005
Changes in patient characteristics and outcomes for radical cystectomy in EnglandMartin C Nuttall, Jan van der Meulen, Gregor McIntosh, et al.
BJU International|November 16, 2004
Threshold volumes for urological cancer surgery: a survey of UK urologistsMartin C Nuttall, Jan van der Meulen, Gregor McIntosh, et al.
BJU International|December 22, 2004
A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial resultsJon-Paul Meyer, Brent Drake, James Boorer, et al.
BMJ Open|October 7, 2017
Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative studyFrances Rapport, Anne Hogden, Howard Gurney, et al.
BJU International|May 7, 2015
Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocolAnthony Koupparis, Christian Villeda-Sandoval, Nicola Weale, et al.
BJU International|May 12, 2010
Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer RegistryGerard P McVey, Sean McPhail, Sarah Fowler, et al.
Cancer Letters|October 3, 2015
Proteomics discovery of radioresistant cancer biomarkers for radiotherapyLei Chang, Peter Graham, Jingli Hao, et al.
Translational Andrology and Urology|August 9, 2023
Novoglan device for treatment of adult phimosis: Novoglan-01 open-label clinical trial on safety, efficacy and tolerabilityEric Chung, Dmitry Polikarpov, Hubert Mazure, et al.
Pageof 8